Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DR26FCRH2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,591.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,591.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL auto-injector units. The delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation, reflecting the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing at its Park Ridge facility and will deliver these pharmaceutical products to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. This structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCRH2?
SPE2DR26FCRH2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FCRH2 worth?
The government has obligated $11,591 on SPE2DR26FCRH2.
Is contract SPE2DR26FCRH2 an order under another contract?
Yes. SPE2DR26FCRH2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRH2 competed?
The extent of competition for SPE2DR26FCRH2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award